Literature DB >> 6209388

Stimulation of inositol trisphosphate accumulation and amylase secretion by caerulein in pancreatic acini.

R P Rubin.   

Abstract

Inositol trisphosphate (IP3), formed by receptor-mediated breakdown of triphosphoinositide, may function as the messenger to mobilize Ca++ in certain cells. The effects of the peptidergic agonist caerulein on the formation of IP3 and amylase secretion in rat pancreatic acini prelabeled with [3H]inositol have therefore been compared. Caerulein elicited rapid increases in [3H]IP3, which subsequently declined after 2 min. Inositol bisphosphate and inositol phosphate, which are produced by the degradative action of phosphatase on IP3, were also increased. Lithium enhanced the action of caerulein on the accumulation of inositol phosphates at later time periods (5-30 min), but failed to augment the secretory response to caerulein. In the presence of lithium, the time course and the concentration-response curves of caerulein-stimulated IP3 accumulation and amylase secretion increased in a parallel fashion; however, IP3 accumulation continued to increase with higher caerulein concentrations than those which elicited maximal enzyme secretion. These findings fortify the concept that peptidergic receptor agonists, like muscarinic agonists, express their effects on the secretory process of the exocrine pancreas through the formation of IP3 derived from the hydrolysis of triphosphoinositide. The mechanism of this event seems to involve spare receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209388

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Serum amylase in patients treated with lithium.

Authors:  A Tham; L Johnson; A A Mathé
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  The role of phosphoinositides in signal transduction.

Authors:  M C Sekar; L E Hokin
Journal:  J Membr Biol       Date:  1986       Impact factor: 1.843

3.  Diminished agonist-stimulated inositol trisphosphate generation blocks stimulus-secretion coupling in mouse pancreatic acini during diet-induced experimental pancreatitis.

Authors:  R E Powers; A K Saluja; M J Houlihan; M L Steer
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

4.  Caerulein and carbamoylcholine stimulate pancreatic amylase release at resting cytosolic free Ca2+.

Authors:  R Bruzzone; T Pozzan; C B Wollheim
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

5.  Muscarinic, alpha 1-adrenergic and peptidergic agonists stimulate phosphoinositide hydrolysis and regulate mucin secretion in rat submandibular gland cells.

Authors:  N Fleming; P T Bilan; E Sliwinski-Lis; V Carvalho
Journal:  Pflugers Arch       Date:  1987-08       Impact factor: 3.657

6.  Lithium dampens neurotransmitter response in smooth muscle: relevance to action in affective illness.

Authors:  H A Menkes; J M Baraban; A N Freed; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  Enzymic dephosphorylation of D-myo-inositol 1,4-bisphosphate in rat brain.

Authors:  A Delvaux; C Erneux; C Moreau; J E Dumont
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

8.  Inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate formation in Ca2+-mobilizing-hormone-activated cells.

Authors:  G M Burgess; J S McKinney; R F Irvine; J W Putney
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

9.  Lithium stimulates accumulation of second-messenger inositol 1,4,5-trisphosphate and other inositol phosphates in mouse pancreatic minilobules without inositol supplementation.

Authors:  J F Dixon; L E Hokin
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

10.  Pancreatic amylase secretion and cytoplasmic free calcium. Effects of ionomycin, phorbol dibutyrate and diacylglycerols alone and in combination.

Authors:  J E Merritt; R P Rubin
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.